news
Novartis drug Afinitor® recommended by CHMP for EU approval
22 July 2011 | By Novartis
The Committee for Medicinal Products for Human Use of the EMA adopted a positive opinion for Afinitor® (everolimus) tablets...
List view / Grid view
Novartis
news
Novartis begins shipment of Fluvirin®
15 July 2011 | By Novartis
Novartis announced that the Company has started shipping seasonal influenza vaccine to its US customers for the 2011-2012 influenza season...
news
Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
news
Novartis drug Afinitor® met primary endpoint of Phase III study
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
news
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
news
Novartis receives approval in Japan for Onbrez® Inhalation Capsules
1 July 2011 | By Novartis
Novartis has received regulatory approval in Japan for Onbrez® Inhalation Capsules (indacaterol)...
news
Novartis Phase III study shows once-daily NVA237 is superior to placebo
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
news
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
news
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant
16 June 2011 | By Novartis
Construction of this facility represents the most significant Novartis investment in Russia...
news
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
16 June 2011 | By Novartis
The US FDA has accepted for review its supplemental Biologics License Application...
news
Horizon successfully completes pilot human gene-editing program
14 June 2011 | By Zyme Communications Ltd
Horizon Discovery has announced that it has successfully completed an eighteen month pilot program with Novartis...
news
Novartis candidate vaccine Bexsero® shows potential against meningococcal serogroup B infections
10 June 2011 | By Novartis
New data from a pivotal study in more than 1,800 infants...
news
Novartis gains European Commission approval for Lucentis®
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
news
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
news
Novartis gains FDA approval for Afinitor®
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
